Of course. I'm merely trying to clarify prior posts which indicate buying AEZS is a no brainer due to its "supposed" high book value. If it were a no brainer the institutions would not have sold out in the quarter following the warrants and the bloggers covering bios would all be posting about AEZS weeks prior to their big news -- which is really nothing that will increase pps even if there is a go-ahead.
News 
Market Data 
Discover 
AI
